id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-256761-rjss51sq	Caputo, Leonardo	Repurposing therapeutic agents and herbal medicines to defeat viral nemesis	2020-03-30		.txt	text/plain	1085	69	43	After a deep analysis and exhaustive illustration of both the rationale behind this tentative approach and related safety concern, Gurwitz suggested that data mining of clinical patient records survived to COVID-19 epidemic might be useful to assess the feasibility of sartans' repurposing as therapeutic treatment to decrease acute respiratory distress syndrome (ARDS) and reduce the aggressiveness from severe acute respiratory syndrome CoV-2 (SARS-CoV-2) infections. Obviously, repurposing old drugs for COVID-19 may start from therapeutic agents with proven efficacy against other lethal viral infections. On the other hand, the use of traditional Chinese remedies as a therapeutic approach for combating SARS-CoV has been well publicized (World Health Organization [WHO], 2003) and it was recently proposed for prevention of COVID-19 (Luo et al., 2020) . Whatever sources of drugs (natural, synthetic, or repurposed) are suggested to be used for COVID-19, their efficacy should be proven through a valid clinical trial.	./cache/cord-256761-rjss51sq.txt	./txt/cord-256761-rjss51sq.txt